<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:department>Physiology and Pharmacology</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/384338DD-D74F-4A45-B592-462BAC4CA355"><gtr:id>384338DD-D74F-4A45-B592-462BAC4CA355</gtr:id><gtr:firstName>Emma</gtr:firstName><gtr:otherNames>Susan</gtr:otherNames><gtr:surname>Robinson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0700980"><gtr:id>A515D8FD-4B53-44D0-9778-0DBD8B558555</gtr:id><gtr:title>Noradrenergic mechanisms in attention and response inhibition</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0700980</gtr:grantReference><gtr:abstractText>Neuroscience research is one of the priority areas identified by the Government and leading health organisations. Recognition of the clinical need for new advances in therapeutic approaches to these diseases is particularly highlighted by statistics revealing an increase in the prevalence of psychiatric and neurodegenerative diseases. The focus of this research project is to investigate the biology of attention deficit hyperactivity disorder (ADHD), a prevalent and debilitating condition in children and adults. ADHD is responsible for significant social and economic costs to society and, although treatments are available, very little is known or understood about how or why they work. To address some of these issues, we can turn to animal models to enable us to dissect the specific brain mechanism that mediate the symptoms and treatment of this disorder. Animals provide a powerful method to study basic brain function and the methods we will use provide an excellent parallel with studies that are carried out in people. Using our animal models we will measure behaviours such as impulsivity, when an action is made that is not properly considered and has negative consequences, and inattention. The experiments will test how current treatments for ADHD act within the brain and isolate which brain areas and chemical processes are involved. The results that we obtained will help us to design future experiments to further refine our understanding of how the brain functions to control behaviour. Importantly, because our models relate closely to psychology test used in humans, we will be able to directly relate our results to the clinical situation. My research is closely linked with human disease and overall this project will identify new ways to alter brain function and improve the treatment of psychiatric conditions such as ADHD.</gtr:abstractText><gtr:technicalSummary>Psychiatric conditions such as attention deficit hyperactivity disorder (ADHD), schizophrenia and drug abuse are characterised by specific deficits in cognitive function and executive processes. Current therapeutic approaches for ADHD involve the use of stimulant and non-stimulant medications with improve symptoms such as inattention and enhance impulse control. There are fundamental problems when addressing the treatment of ADHD, however, as our understanding of the underlying neurobiology of the condition and mechanisms of action of drugs used therapeutically is severely limited. We have recently shown that the noradrenaline (NA) reuptake inhibitor, atomoxetine, improves three distinct forms of impulsivity in the rat. Our research as well as evidence from other groups supports, the hypothesis that cortical increases in catecholamines is an important mechanism by which improvements in impulse control and attention is achieved. Building on these studies and working from this hypothesis, the proposed project will investigate the mechanism of action of atomoxetine-induced improvements in impulse control using animal models of motor impulsivity (the 5-choice serial reaction time task and stop signal reaction time task) and impulsive choice (delay discounting paradigm). To isolate the role of the NA-ergic system in task performance and the efficacy of ADHD medications, a series of experiments are proposed, which utilise new developments in molecular approaches to induce NA-ergic specific neuronal silencing through viral-mediated transgene expression. The results from these experiments will be compared directly with data obtained from animals with neurotoxic lesions (6-hydroxydopamine) of the dorsal noradrenergic nerve bundle. Overall, the programme of research proposed will achieve four key objectives. I. Pharmacological characterisation of ATO-induced decrease in impulsivity, II. Determine the attentional effects of NaRI using modified 5CSRTT, III. Identify the neural basis of ATO-induced improvements in impulse control and IV. Establish the involvement of cortical NA innervations in impulsivity. The utilisation of the viral-vector methodology will also facilitate the development of new approaches to targeting the NA-ergic system in vivo. The results obtained from these experiments will be published in leading international behavioural neuroscience journals and, through this dissemination process and through links with the pharmaceutical industry, this project has the potential to provide an evidential basis for improved pharmacotherapies in ADHD.</gtr:technicalSummary><gtr:fund><gtr:end>2012-04-13</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-08-14</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>254520</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Primary school neuroscience workshop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>DBCAA006-6126-42CE-B1EA-5994488C3C08</gtr:id><gtr:impact>Neuroscience workshop for 25 primary school pupils aged 5-6yrs.

Very positive feedback from pupils, parents and school. invited to return for further sessions with older group.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School animal research talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>764F3A6D-D7F3-4809-8DD0-97E85D5C3DB8</gtr:id><gtr:impact>Groups of 20-60 pupils attended a talk about animal research and addiction. Pupils were given a 30 min talk followed by 30 min of discussion

Schools provided excellent feedback and have asked for return visits</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>A796717D-8D10-41A1-8DAA-4679D97DB6BE</gtr:id><gtr:impact>Groups of 20-40 sixth form pupils.
Discussion about primary research interest and how animal research has enabled these studies and knowledge development to occur.

Positive feedback via UAR and School</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>DANA Centre Addiction Talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>4170BD8B-E679-4118-9C4F-0C11142F521A</gtr:id><gtr:impact>~60 people attended the session which involved three short presentations for professionals and a talk from a recovering addict. The session led to a broad ranging discussion.

No specific follow up but good feedback</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.danacentre.org.uk/events/2013/11/12/713</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interactive science events</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>31E63F1A-00EC-48B4-9FF4-8816610FF1E6</gtr:id><gtr:impact>Use of an interactive 'Neurobot' as part of Brain awareness week and cheltenham science week to discuss principles of neuroscience. Stroop test experiment to show how inhibitory control in the brain affects response times under different conditions

High level of interest in discussing neuroscience and disorders such as ADHD and Alzheimer's</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009,2010,2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ASE teacher conference talk</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6F71498D-02A4-409B-B79D-261CD3F47FFF</gtr:id><gtr:impact>Presentation of a talk on 'Drugs of abuse: Psychoactive and Performance Enhancing Drugs' as part of the 'Biology in the Real World' symposium

Invitation to become a member of the Institute of Biology
Invited review article</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Access to Bristol Course</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>B5689627-B71A-4C1F-AF56-204AA09FFBCE</gtr:id><gtr:impact>Two cohorts of 50 sixth form students from local schools attending an afternoon session in Pharmacology. Session includes a talk and three different practical sessions.

Increased interest in attending university to study biomedical sciences</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Brain Awareness Week</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>F3C07DEA-3A48-4D18-B634-B30002E86CBC</gtr:id><gtr:impact>School groups and families visiting At Bristol Science centre have access to hand on activities relating to Neuroscience.

Good feedback from visitors and teachers as well as the At Bristol organisers</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008,2009,2010,2011,2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Med-associates operant chambers, interface, operating system and (in house designed) analysis packages</gtr:description><gtr:id>2F833A2A-56FA-41CB-8AF5-1A38CB9738B7</gtr:id><gtr:impact>None-study ongoing</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Operant chamber infrastructure</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Modification of an established animal model of attention and impulse control (5CSRTT) leading to an improved method to detect drug actions where an improvement in attention is of interest</gtr:description><gtr:id>9508650F-D3B8-4ED5-B80F-3676754D59CC</gtr:id><gtr:impact>Novel data has been generated showing that a therapuetic intervention for ADHD improves attention in a sub-population of animals indicating an interaction with endogenous catecholamines.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Non-paced version of the rat 5 choice serial reaction time task</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CA300CC8-DE02-45B3-B0C2-2367C3D654C5"><gtr:id>CA300CC8-DE02-45B3-B0C2-2367C3D654C5</gtr:id><gtr:title>Investigating the psychopharmacology of cognitive affective bias in rats using an affective tone discrimination task.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/017e260cc92612f8c35c0c0afeec6a8f"><gtr:id>017e260cc92612f8c35c0c0afeec6a8f</gtr:id><gtr:otherNames>Anderson MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4C3CD957-9E15-4A16-8220-43DEB9A5E39F"><gtr:id>4C3CD957-9E15-4A16-8220-43DEB9A5E39F</gtr:id><gtr:title>Blockade of noradrenaline re-uptake sites improves accuracy and impulse control in rats performing a five-choice serial reaction time tasks.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e4ff3e2b6ac0aa2e78383f7b6e1f0aa8"><gtr:id>e4ff3e2b6ac0aa2e78383f7b6e1f0aa8</gtr:id><gtr:otherNames>Robinson ES</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4B8A7C83-9E31-4CF7-B69A-8AC5F1614889"><gtr:id>4B8A7C83-9E31-4CF7-B69A-8AC5F1614889</gtr:id><gtr:title>Investigating the roles of different monoamine transmitters and impulse control using the 5-choice serial reaction time task.</gtr:title><gtr:parentPublicationTitle>Journal of psychopharmacology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9917d3087e8943d7baea0f71ce2b8bf3"><gtr:id>9917d3087e8943d7baea0f71ce2b8bf3</gtr:id><gtr:otherNames>Humpston CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0269-8811</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0A42ED8F-62EA-4258-9CEB-6CE2CD796820"><gtr:id>0A42ED8F-62EA-4258-9CEB-6CE2CD796820</gtr:id><gtr:title>Differential roles for cortical versus sub-cortical noradrenaline and modulation of impulsivity in the rat.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0b00c4fd5e38e82aada5100449e6bffc"><gtr:id>0b00c4fd5e38e82aada5100449e6bffc</gtr:id><gtr:otherNames>Benn A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C78DE647-E692-41E5-A7D5-92AF062CAD70"><gtr:id>C78DE647-E692-41E5-A7D5-92AF062CAD70</gtr:id><gtr:title>Brain chemistry and behaviour: an update on neuroscience research and its implications for understanding drug addiction</gtr:title><gtr:parentPublicationTitle>School Science Reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/55e7a7720276e72b8f936e71d0065748"><gtr:id>55e7a7720276e72b8f936e71d0065748</gtr:id><gtr:otherNames>Robinson Emma</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FDB8581F-16ED-45ED-865E-7F25A06B9392"><gtr:id>FDB8581F-16ED-45ED-865E-7F25A06B9392</gtr:id><gtr:title>Modelling cognitive affective biases in major depressive disorder using rodents.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1e87899bfb85079cd1f3cf681b753707"><gtr:id>1e87899bfb85079cd1f3cf681b753707</gtr:id><gtr:otherNames>Hales CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700980</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>